Grifols (GIKLY) Shareholder's Equity Growth (1y) (2011 - 2025)

Grifols (GIKLY) Shareholder's Equity Growth (1y) (2011 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.40%
Dec 31, 2024 -22.23%
Dec 31, 2023 -0.68%
Dec 31, 2022 3.73%
Dec 31, 2021 1,539.99%
Dec 31, 2020 -107.19%
Dec 31, 2019 41.35%
Dec 31, 2018 25.29%
Jun 30, 2018 20.32%
Dec 31, 2017 6.30%
Jun 30, 2017 2.19%
Dec 31, 2016 11.23%
Sep 30, 2016 10.70%
Dec 31, 2015 8.73%
Dec 31, 2014 36.86%
Dec 31, 2013 5.39%
Sep 30, 2013 14.89%
Jun 30, 2013 -0.93%
Mar 31, 2013 17.04%
Dec 31, 2012 2.98%